Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer
2014 ◽
Vol 21
(4)
◽
pp. 181-191
◽
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽